BRD2 and polycystic ovary syndrome: It was found that in PCOS women with higher bLH/FSH and higher serum AMH levels, severe OHSS incidence was higher in the follicular phase GnRH agonist group, but among PCOS women with lower bLH/FSH and lower AMH levels, severe OHSS incidence between the two groups was similar.